Biogen to acquire Pfizer’s Phase 2b – ready compound
Biogen Inc. will acquire from Pfizer Inc. a Phase 2b-ready compound designed to treat cognitive impairment associated with schizophrenia. Biogen will pay... Read More
Deal Insight: Daiichi Sankyo, DarwinHealth R&D agreement
Daiichi Sankyo Company, Limited and DarwinHealth announced they have entered into a research agreement providing Daiichi Sankyo with exclusive access to DarwinHealth’s... Read More
Glenmark and Helsinn Group’s exclusive licensing deal for launch of Akynzeo in India and Nepal
Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, and Helsinn Group (“Helsinn”), a Swiss pharmaceutical group focused on building quality cancer... Read More
Case Study: GSK to acquire Novartis’s consumer healthcare stake for $13bn
Posted on28 Mar 2018
Tagsacquisition in pharma, brand acquisition, GSK, novartis, OTC drugs, otc monograph, pharma acquisition
Comments0
Swiss drugmaker, Novartis agreed to sell GSK its stake in their consumer health joint venture for $13bn. GlaxoSmithKline will be getting the... Read More
Cipla – Roche Deal – Cipla will promote and distribute Roche’s tocilizumab and Syndyma in India
Cipla Ltd and Roche Pharma India has entered an agreement under which Cipla will promote and distribute tocilizumab and Syndyma, the 2nd... Read More
Astellas to acquire Universal Cells for up to $102.5M
Astellas Pharma has acquired Seattle, WA-based Universal Cells, Inc. and its Universal Donor Cell technology enabling the creation of cell therapy products... Read More
Case Study: Sanofi’s acquisition of Ablynx for $4.8 bn
French drugmaker Sanofi has agreed to acquire Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion). This is second deal of... Read More
Novatis’ LUTATHERA® Approval: First FDA Approval for a Peptide Receptor Radionuclide Therapy (PRRT)
Advanced Accelerator Applications S.A., a Novartis company and leader in nuclear medicine theragnostics, today announced that it has received US Food and... Read More
Pharma Case Study: Backward Integration: Ipca Laboratories acquisition of Pisgah Labs Inc.
What is backward integration? Backward integration strategy employed to expand profits and gain greater control over production of a product whereby a company... Read More
Licensing Case Study: Nuvo Ireland’s acquisition of US rights for Resultz from Piedmont Pharma
Posted on17 Jan 2018
Comments0
Nuvo Pharmaceuticals Inc. (Nuvo), a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, announced that its wholly... Read More